The phrase "actual progression" is correct and usable in written English.
It can be used to refer to the real or true advancement or development in a particular context, such as a project or personal growth.
Example: "The actual progression of the project has been slower than anticipated due to unforeseen challenges."
Alternatives: "real advancement" or "true development".
The actual progression is from white to black, which may sound like a fadeout but feels like a prison break.
Additionally the following graph I found shows the actual progression of monthly active users for the past month.
Though the new findings highlight a way to improve the quality of life for people living with Alzheimer's, some scientists caution that there is still no evidence to suggest that exercise and a change in environment can slow the actual progression of the disease.
A history of the last minute of heartbeats is kept in memory to determine the actual progression of load.
We compared our projected paths of steepest descent to the lava flow's actual progression using a time-series of flow outline GIS polygons provided by USGS and Civil Defense.
The actual progression of the measurement can be stored and used later for a graphical presentation of the measuring curve.
Hence, it is highly expected that actual progression-free survival will be different between low/negative and high/positive IPFU, as the latter might represent the integration of these poor-prognosis pathological features that are only known after surgery.
Certainly, the gold standard to demonstrate the prognostic value of FDG-PET/CT will be our cohort's actual progression-free survival, which will be assessed in the upcoming years.
7 In this validation, the progression-free survival predicted for the simulated patients treated with alemtuzumab and chlorambucil (when setting input parameters including patient characteristics, time horizon, and response rates to be an exact match of the alemtuzumab trial) were compared with the actual progression-free survival reported in that study.
For patients 'off' treatment, the model uses a matrix of transition probabilities derived from the actual progressions seen in the 'natural history' comparator cohort.
For patients "off" treatment, the ScHARR model uses a matrix of transition probabilities derived from the actual progressions seen in the Ontario dataset (using a subset of 314 patients who were judged to have fulfilled the Association of British Neurologists' criteria experiencing two or more relapses in the previous two years at baseline).
